期刊文献+

瑞舒伐他汀对慢性心力衰竭患者血清细胞因子及心功能的影响 被引量:5

Influences of rosuvastatin on serum cytokines and cardiac function of patients with chronic heart failure
下载PDF
导出
摘要 目的探究瑞舒伐他汀对慢性心力衰竭患者血清细胞因子和心功能的影响。方法选择广州市中医医院2014年5月到2015年5月收治的70例慢性心力衰竭患者,随机分为观察组和对照组,各35例。对照组采取抗心力衰竭常规治疗,观察组在常规治疗的基础上给予瑞舒伐他汀治疗。比较两组血清细胞因子水平以及心功能指标变化情况。结果观察组治疗后肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)以及超敏C反应蛋白(hs-CRP)水平均显著低于对照组,差异有统计学意义(P<0.05)。观察组治疗后LVESV水平显著低于对照组(P<0.05),LVEF显著高于对照组(P<0.05)。结论采用瑞舒伐他汀治疗慢性心力衰竭患者可显著调节血清细胞因子水平,改善心功能,值得临床广泛推广。 Objective To investigate the influences of rosuvastatin on serum cytokines and cardiac function of patients with chronic heart failure. Methods 70 patients with chronic heart failure treated in Guangzhou Hospital of TCM from May of 2014 to May of 2015 were randomly divided into observation group and control group,35 cases in each. The control group was given conventional anti- heart failure treatment,observation group was given rosuvastatin treatment on the basis of conventional therapy.The serum cytokine levels and cardiac function indicators were compared between two groups. Results After treatment,the levels of tumor necrosis factor- α( TNF- α),interleukin- 6( IL- 6) and high- sensitivity C- reactive protein( hs- CRP) in observation group were significantly lower than the control group,the difference was statistically significant( P〈0. 05). The level of LVESV in observation group was significantly lower than the control group( P〈0. 05); LVEF was significantly higher than control group( P〈0. 05). Conclusion Rosuvastatin could regulate the levels of serum cytokines,improve the cardiac function.It deserves the clinical expansion.
作者 彭兰兰
出处 《河南医学研究》 CAS 2015年第7期17-18,共2页 Henan Medical Research
关键词 瑞舒伐他汀 心力衰竭 细胞因子 心功能 rosuvastatin heart failure cytokines cardiac function
  • 相关文献

参考文献4

二级参考文献38

  • 1张辉,郭杰.高压氧对冠心病患者C-反应蛋白的影响[J].中华航海医学与高气压医学杂志,2005,12(1):41-42. 被引量:11
  • 2王建富,高文献,李晶,秦连芝,李钦萍,胡爱东,刘成华.高压氧治疗对冠状动脉支架置入术后支架内再狭窄的影响[J].中华物理医学与康复杂志,2005,27(12):757-759. 被引量:7
  • 3周秀华,马冬岩.高压氧对慢性充血性心力衰竭患者血循环内皮细胞及脑钠素的影响[J].北华大学学报(自然科学版),2006,7(3):243-244. 被引量:9
  • 4Wada T,Furuichi K, Sakai N, et al. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int ,2000,58 (4) : 1492-1499.
  • 5Wang J , Li F,Calhoum JH,et al. The role and effectiveness of adjunctive hyperbaric oxygen in the management of musculoskeletal disorders. J Postgrad Med, 2002,48 ( 3 ) : 226 - 231.
  • 6Marrugat J, Subirana I, Comin E, et al. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA study. J Epidemiol Community Health, 2007, 61 ( 1 ) :40-47.
  • 7] Reilly MP, Lehrke M, Wolfe ML, et al. Resistin is an inflammatory marker of atherosclerosis in human. Circulation, 2005,111 (7) :932- 939.
  • 8Hurairah H,Felxo A. The role of the endothelium in the control of vascular function. Int J Clin Pract,2004,58 ( 2 ) : 173- 183.
  • 9Vanhoutte PM. Endothelial control of vasomotor function from health to coronary disease. Cir J,2003,67 (4) :572- 575.
  • 10Hunt SA,Abraham WT,Chin MH,et a/.ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult a report of the American college of cardiology/ American heart association task force on practice guidelines[J].Circulation, 2005,112 (12) : e154-e235.

共引文献22

同被引文献52

引证文献5

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部